Minority-Based Community Clinical Oncology Program Groups
Page 2

The MBCCOP Groups will work by providing patients with access to clinical trials in cancer centers, major university centers, and community programs. And in this manner, this access will be realized through another, separately funded, arm of the program called "Research Bases," which are comprised of participating NCI Cooperative Groups and Cancer Centers.

As a result, the linkages that will soon be developed as a result of this access is expected to facilitate the transfer of advances in cancer prevention/control/treatment practices to minority communities and their physicians.

The National Institutes of Health is ready to administer funds in the amount of $5,500,000 to support the Minority-Based Community Clinical Oncology Program Groups.

The institutions and organizations who will be deemed eligible to submit an application under this program are the following:

a) Public and State Controlled Institutions of Higher Education

b) Native American Tribal Governments

c) Federally recognized Native American Tribal Organizations

d) Nonprofit Organizations

e) Private Institutions of Higher Education

f) For-profit organizations

g) Small businesses

The United States Department of Health and Human Services, the mother agency funding the program, is the nation's premiere agency for protecting the health of all Americans and providing essential human services to everyone, especially to those who are medically challenged and financially vulnerable.

Minority-Based Community Clinical Oncology Program Groups
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Combating Autism Act Initiative: National Interdisciplinary Training Resource Center Program
In keeping with this mission, the Health Resources and Services Administration has recently announced the establishment of the Combating Autism Act Initiative: National Interdisciplinary Training Resource Center Program wherein it aims to solicit applications from eligible entities that seek to run and manage a National Interdisciplinary Training Resource Center.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---